StrongBox Wealth LLC Raises Stake in Danaher Co. (NYSE:DHR)

StrongBox Wealth LLC increased its stake in shares of Danaher Co. (NYSE:DHRGet Rating) by 3.6% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 10,196 shares of the conglomerate’s stock after purchasing an additional 354 shares during the period. Danaher accounts for 1.7% of StrongBox Wealth LLC’s investment portfolio, making the stock its 17th largest position. StrongBox Wealth LLC’s holdings in Danaher were worth $2,585,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in DHR. US Asset Management LLC increased its stake in Danaher by 0.6% in the 1st quarter. US Asset Management LLC now owns 5,774 shares of the conglomerate’s stock worth $1,694,000 after acquiring an additional 37 shares during the last quarter. Mairs & Power Inc. increased its stake in Danaher by 4.1% in the 4th quarter. Mairs & Power Inc. now owns 959 shares of the conglomerate’s stock worth $316,000 after acquiring an additional 38 shares during the last quarter. Mutual Advisors LLC increased its stake in Danaher by 0.7% in the 4th quarter. Mutual Advisors LLC now owns 5,792 shares of the conglomerate’s stock worth $1,906,000 after acquiring an additional 40 shares during the last quarter. Encompass Wealth Advisors LLC increased its stake in Danaher by 1.9% in the 1st quarter. Encompass Wealth Advisors LLC now owns 2,292 shares of the conglomerate’s stock worth $672,000 after acquiring an additional 42 shares during the last quarter. Finally, Howe & Rusling Inc. increased its position in shares of Danaher by 48.8% during the 1st quarter. Howe & Rusling Inc. now owns 128 shares of the conglomerate’s stock valued at $38,000 after purchasing an additional 42 shares during the last quarter. Hedge funds and other institutional investors own 77.27% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Barclays increased their price objective on Danaher from $290.00 to $310.00 in a research report on Friday, July 22nd. Sanford C. Bernstein started coverage on Danaher in a research report on Tuesday, August 16th. They set an “outperform” rating and a $340.00 price target on the stock. Robert W. Baird raised their price target on Danaher from $319.00 to $325.00 in a research report on Friday, July 22nd. KeyCorp reduced their price target on Danaher from $345.00 to $325.00 and set an “overweight” rating on the stock in a research report on Friday, July 22nd. Finally, StockNews.com upgraded Danaher from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 26th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $321.75.

Insider Activity

In other news, CEO Rainer Blair sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $300.00, for a total value of $7,500,000.00. Following the completion of the transaction, the chief executive officer now owns 79,739 shares in the company, valued at approximately $23,921,700. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Danaher news, EVP Joakim Weidemanis sold 12,000 shares of Danaher stock in a transaction on Monday, July 25th. The stock was sold at an average price of $271.13, for a total transaction of $3,253,560.00. Following the completion of the transaction, the executive vice president now owns 74,398 shares in the company, valued at $20,171,529.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Rainer Blair sold 25,000 shares of Danaher stock in a transaction on Monday, August 15th. The shares were sold at an average price of $300.00, for a total value of $7,500,000.00. Following the transaction, the chief executive officer now owns 79,739 shares of the company’s stock, valued at approximately $23,921,700. The disclosure for this sale can be found here. Insiders sold a total of 40,906 shares of company stock worth $11,823,179 in the last quarter. 11.20% of the stock is owned by company insiders.

Danaher Trading Down 0.9 %

NYSE DHR traded down $2.41 on Friday, hitting $264.02. The company’s stock had a trading volume of 46,328 shares, compared to its average volume of 2,203,832. The firm has a market cap of $192.06 billion, a P/E ratio of 31.38, a PEG ratio of 1.29 and a beta of 0.88. The company has a current ratio of 1.75, a quick ratio of 1.32 and a debt-to-equity ratio of 0.45. The company’s 50-day simple moving average is $280.99 and its 200 day simple moving average is $269.91. Danaher Co. has a 52-week low of $233.71 and a 52-week high of $331.68.

Danaher (NYSE:DHRGet Rating) last released its earnings results on Thursday, July 21st. The conglomerate reported $2.76 EPS for the quarter, beating analysts’ consensus estimates of $2.35 by $0.41. The company had revenue of $7.75 billion during the quarter, compared to analysts’ expectations of $7.29 billion. Danaher had a return on equity of 18.57% and a net margin of 20.61%. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the business posted $2.46 EPS. Research analysts predict that Danaher Co. will post 10.4 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date of this dividend is Thursday, September 29th. Danaher’s payout ratio is presently 11.78%.

About Danaher

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

See Also

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.